Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT01515527 · RECRUITING
Trial details
- NCT number
- NCT01515527
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-07
- Primary completion
- 2028-02-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.